DK1784181T3 - VEGF-hæmning - Google Patents

VEGF-hæmning

Info

Publication number: DK1784181T3
Authority: DK; Denmark
Prior art keywords: vegf inhibition; vegf; inhibition
Prior art date: 2004-08-31

Application number

DK05776195.9T

Other languages

English (en)

Inventor

David L Morris

Mohammad Hossein Pourgholami

Original Assignee

Newsouth Innovations Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-31

Filing date

2005-08-31

Publication date

2013-09-02

2004-08-31 Priority claimed from AU2004904972A external-priority patent/AU2004904972A0/en

2005-08-31 Application filed by Newsouth Innovations Pty Ltd filed Critical Newsouth Innovations Pty Ltd

2013-09-02 Application granted granted Critical

2013-09-02 Publication of DK1784181T3 publication Critical patent/DK1784181T3/da

Links

102000005789 Vascular Endothelial Growth Factors Human genes 0.000 title 1
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 title 1
230000005764 inhibitory process Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Vascular Medicine (AREA)
Reproductive Health (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK05776195.9T 2004-08-31 2005-08-31 VEGF-hæmning DK1784181T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
AU2004904972A AU2004904972A0 (en)		2004-08-31	VEGF Inhibition
AU2004904973A AU2004904973A0 (en)		2004-08-31	Treatment for Ascites
PCT/AU2005/001318 WO2006024092A1 (en)	2004-08-31	2005-08-31	Vegf inhibition

Publications (1)

Publication Number	Publication Date
DK1784181T3 true DK1784181T3 (da)	2013-09-02

Family

ID=35999633

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05776195.9T DK1784181T3 (da)	2004-08-31	2005-08-31	VEGF-hæmning

Country Status (11)

Country	Link
US (1)	US8912225B2 (da)
EP (1)	EP1784181B1 (da)
JP (1)	JP5022220B2 (da)
KR (1)	KR20070083538A (da)
CN (1)	CN101035530B (da)
CA (1)	CA2576827A1 (da)
DK (1)	DK1784181T3 (da)
ES (1)	ES2425750T3 (da)
PL (1)	PL1784181T3 (da)
PT (1)	PT1784181E (da)
WO (1)	WO2006024092A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20070083538A (ko)	2004-08-31	2007-08-24	뉴사우스 이노베이션즈 피티와이 리미티드	Ｖｅｇｆ 억제
WO2009043093A1 (en) *	2007-10-04	2009-04-09	Newsouth Innovations Pty Limited	Hif inhibition
EP2251010A1 (en)	2009-05-08	2010-11-17	Sygnis Bioscience GmbH & Co. KG	Use of thiabendazole and derivatives thereof for the therapy of neurological conditions
WO2010135534A2 (en) *	2009-05-20	2010-11-25	Children's Medical Center Corporation	Compositions for the treatment of metastatic cancer and methods of use thereof
CN102336740B (zh) *	2010-07-27	2013-07-24	中国科学院上海药物研究所	一类咪唑类化合物及其用途
CN103054858A (zh) *	2013-01-21	2013-04-24	杭州雷索药业有限公司	奥苯达唑在制备抗血管生成类药物中的应用
KR20210099402A (ko) *	2020-02-04	2021-08-12	고려대학교 산학협력단	펜벤다졸, 옥시벤다졸 또는 이들의 혼합물을 포함하는 자궁내막 세포 또는 영양막 세포의 비정상적 증식 관련 질환의 예방 또는 치료용 약학적 조성물
CA3171779A1 (en) *	2020-03-14	2021-09-23	Levon Michael Khachigian	Compounds and pharmaceutical compositions for reducing vascular permeability,neovascularisation,angiogenesis,inflammation,cell migration and/or cell proliferation,and to methods for inhibiting fosb/.delta.fosb expression and/or erk1/2 phosphorylation and/or vcam-1 expression.
CN113648308A (zh) *	2021-09-14	2021-11-16	东莞市人民医院	奥芬达唑作为抗卵巢癌药物的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9900752D0 (en) *	1999-01-15	1999-03-03	Angiogene Pharm Ltd	Benzimidazole vascular damaging agents
IL145941A (en) *	1999-04-28	2007-08-19	Univ Texas	Compositions and methods for cancer treatment by selectively inhibiting vegf
WO2000066161A1 (en)	1999-04-28	2000-11-09	Takeda Chemical Industries, Ltd.	Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy
JP2002193947A (ja)	2000-12-26	2002-07-10	Taisho Pharmaceut Co Ltd	ベンズイミダゾール誘導体
JP4688291B2 (ja) *	2000-12-28	2011-05-25	株式会社コーセー	油性メイクアップ化粧料
US7423015B1 (en) *	2001-01-11	2008-09-09	Board Of Regents, The University Of Texas System	Antihelminthic drugs as a treatment for hyperproliferative diseases
US6693125B2 (en) *	2001-01-24	2004-02-17	Combinatorx Incorporated	Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
CA2342470A1 (en) *	2001-03-30	2002-09-30	David Lawson Morris	Method for treatment of cancer and benzimidazole compositions for use therein
WO2002076454A1 (en)	2001-03-26	2002-10-03	Unisearch Limited	Method for treatment of cancer and compositions for use therein
KR20070083538A (ko)	2004-08-31	2007-08-24	뉴사우스 이노베이션즈 피티와이 리미티드	Ｖｅｇｆ 억제

2005
- 2005-08-31 KR KR1020077005203A patent/KR20070083538A/ko not_active Withdrawn
- 2005-08-31 JP JP2007528523A patent/JP5022220B2/ja not_active Expired - Fee Related
- 2005-08-31 PL PL05776195T patent/PL1784181T3/pl unknown
- 2005-08-31 WO PCT/AU2005/001318 patent/WO2006024092A1/en not_active Ceased
- 2005-08-31 CA CA002576827A patent/CA2576827A1/en not_active Abandoned
- 2005-08-31 EP EP05776195.9A patent/EP1784181B1/en not_active Expired - Lifetime
- 2005-08-31 PT PT57761959T patent/PT1784181E/pt unknown
- 2005-08-31 DK DK05776195.9T patent/DK1784181T3/da active
- 2005-08-31 CN CN2005800292583A patent/CN101035530B/zh not_active Expired - Fee Related
- 2005-08-31 US US11/661,460 patent/US8912225B2/en not_active Expired - Fee Related
- 2005-08-31 ES ES05776195T patent/ES2425750T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
PT1784181E (pt)	2013-08-26
EP1784181A4 (en)	2009-06-03
US8912225B2 (en)	2014-12-16
CN101035530B (zh)	2013-07-03
PL1784181T3 (pl)	2013-10-31
US20090105317A1 (en)	2009-04-23
EP1784181B1 (en)	2013-08-07
JP2008511549A (ja)	2008-04-17
JP5022220B2 (ja)	2012-09-12
EP1784181A1 (en)	2007-05-16
KR20070083538A (ko)	2007-08-24
CA2576827A1 (en)	2006-03-09
HK1103651A1 (en)	2007-12-28
ES2425750T3 (es)	2013-10-17
CN101035530A (zh)	2007-09-12
WO2006024092A1 (en)	2006-03-09

Publication	Publication Date	Title
CY2019034I2 (el)	2019-11-27	4-φαινυλαμινο-κιναζολιν-6-υλ-αμιδια
EP1737290A4 (en)	2008-04-02	Corn event mir604
EP1730337A4 (en)	2010-03-17	INORGANIC NANODRICES
DE602004011270D1 (de)	2008-02-21	Auslasszusatzmodul
DE502005005628D1 (de)	2008-11-20	Wischblatt
DE602004022207D1 (de)	2009-09-03	Detergenzabgabevorrichtung
EP1790281A4 (en)	2009-08-05	DIOPSIMETER
DE602005006955D1 (de)	2008-07-03	Klopferkennung
DE502005004843D1 (de)	2008-09-04	Einspritzventil
DE502005006395D1 (de)	2009-02-12	Verschlusskappe
FI20041311A0 (fi)	2004-10-08	Lohkomodulaatio
DE602005003991D1 (de)	2008-02-07	Gleichlauftripodegelenk
EP1719757A4 (en)	2009-10-21	Bicyclo derivative
DE502004006772D1 (de)	2008-05-21	Wirkwerkzeug-Barre
DE602005026084D1 (de)	2011-03-10	Tintenstrahlkopfanornung
DE502005008587D1 (de)	2010-01-07	Kugelgelenk
DE602005003649D1 (de)	2008-01-17	Hydraulikhammer
DE602005021608D1 (de)	2010-07-15	Plasmaanzeigetafelansteuerverfahren
DE502005002602D1 (de)	2008-03-13	Fahrzeugtemperiersystem
DE502005004695D1 (de)	2008-08-28	Sicherheitsfangseil
DE602005025288D1 (de)	2011-01-27	Flugzeugstart
EP1732098A4 (en)	2009-05-13	BREAKER
DE602005000183D1 (de)	2006-11-30	Leitweglenkungsarchitektur
DE112005001019A5 (de)	2007-05-24	Kunststoffschraubverschlusskappe
DE502004007607D1 (de)	2008-08-28	Falzschwertantrieb